The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s arrhythmia market report forecasts the arrhythmia market size to grow to $9.82 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Arrhythmia Market Report 2023 – https://www.thebusinessresearchcompany.com/report/arrhythmia-global-market-report

Arrhythmia Market Size Forecast
The global arrhythmia market is expected to grow from $6.93 billion in 2022 to $7.44 billion in 2023, at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The arrhythmia market size is expected to grow to $9.82 billion in 2027 at a CAGR of 7.2%.

North America held the largest arrhythmia market share.

Key Arrhythmia Market Driver ­– Rise In The Prevalence Of Cardiac Disease And Other Heart Problems
For instance, in October 2022, according to the CDC (Centers for Disease Control and Prevention), a US-based government agency, every year in the United States, there were estimated to be 69.7k heart disease-related deaths and 80.5k heart attacks every year.[i] Thus, the rising prevalence of cardiac disease and other heart problems is driving the growth of the arrhythmia market.

Request for A Sample Of The Global Arrhythmia Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8018&type=smp

Key Arrhythmia Market Trend – Adopting New Therapies For Treatment
Major players operating in the market are advancing toward developing new therapies, such as cryoablation therapy, an innovative treatment used in patients with arrhythmias. For instance, in November 2021, Aster Medcity, an India-based quaternary care healthcare center, launched the state-of-the-art heart disease treatment Cryoablation Therapy, an innovative procedure that inhibits abnormal electrical pathways that cause strokes and heart failures and restores a normal heartbeat. Using advanced imaging technology, the catheter is passed through a blood vessel in the patient’s leg and routed to the heart. Nitrous oxide gas is injected into a cryoballoon, which cools the tissue and produces ablation lesions inside the heart. By using a balloon and a low temperature, this treatment is capable of completing the process without damaging other cells.

Arrhythmia Market Segment
1) By Type: Supraventicular Tachycardias, Ventricular Arrhythmias, Bradyarrhythmias, Other Types
2) By Test Equipment: Electrocardiogram (ECG), Holter Monitor
3) By Hearth blocks: First degree heart block, Second degree heart block, Third Degree heart block
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Arrhythmia Market Major Players and Strategies
Major players in the arrhythmia market are Medtronic plc, Abbott Laboratories, Boston Scientific, AliveCor, Biotronik, Biotricity, GE HealthCare, Koninklijke Philips NV, Nihon Kohden Corporation, Spacelabs Healthcare, Welch Allyn Inc., Mylan NV, Mayne Group, Sanofi SA, and Lepu Medical Technology Company.

In August 2022, Medtronic, an Ireland-based healthcare technology company, acquired Affera for an undisclosed amount. The addition of a cardiac ablation portfolio by Medtronic, which includes the company’s first-ever cardiac mapping and navigation technology, would enable it to better serve patients with cardiac arrhythmias. Affera is a US-based medical technology company that provides innovative solutions for cardiac arrhythmia treatment.

The Arrhythmia Global Market Report 2023 covers regional data on arrhythmia market size, arrhythmia market trends and drivers, opportunities, strategies, and arrhythmia market competitor analysis. The countries covered in the arrhythmia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Arrhythmia refers to a heart disorder caused by an abnormality in the normal sequence of electrical impulses, which changes the rate or rhythm at which the heart beats. Electrical impulses can be too fast, too slow, or erratically occurring, resulting in irregular heartbeats.

View More Reports Related To The Arrhythmia Market –
Arrhythmia Monitoring Devices Global Market Report 2023
Cardiac Arrhythmia Monitoring Devices Global Market Report 2023
Cardiac Pacemakers Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: